Kathleen D. Scott
Director, Histogen Inc.
Companies
- NKGen Biotech, Inc.Board member Oct 10, 2023 to now1
- Silverback TherapeuticsChief financial officer Nov 10, 2022 to now2
- Dermata Therapeutics, Inc.Board member Aug 12, 2021 to now3
- Histogen Inc.Board member Nov 19, 2019 to Nov 19, 20194
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Silverback Therapeutics SPRY18,292 shares5$78.4K at $4.29Aug 22, 2025- Dermata Therapeutics, Inc. DRMA1 shares6$1 at $0.87Jun 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026Sold 11 shares at $1.19 of Dermata Therapeutics, Inc.6
- Aug 21, 2025Sold 12,500 shares at $15.00 of Silverback Therapeutics5
- Aug 21, 2025Exercised options 12,500 shares at $1.50 of Silverback Therapeutics5
- May 20, 2025Sold 50,000 shares at $14.10 of Silverback Therapeutics7
- May 20, 2025Exercised options 50,000 shares at $1.50 of Silverback Therapeutics7
- Oct 16, 2024Sold 12,500 shares at $16.00 of Silverback Therapeutics8
- Oct 16, 2024Exercised options 12,500 shares at $1.50 of Silverback Therapeutics8
- Aug 20, 2024Sold 12,500 shares at $16.00 of Silverback Therapeutics9
- Aug 20, 2024Exercised options 12,500 shares at $1.50 of Silverback Therapeutics9
- Nov 29, 2022Bought 8,250 shares at $6.24 of Silverback Therapeutics10
- Oct 6, 2022Granted 11,359 shares of Dermata Therapeutics, Inc.11
- Jul 7, 2022Granted 9,960 shares of Dermata Therapeutics, Inc.12
- Apr 7, 2022Granted 5,826 shares of Dermata Therapeutics, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNKGen Biotech, Inc., Board member
- 2
- 3
- 4SEC EDGARHistogen Inc., Board member
- 5
- 6
- 7SEC EDGARForm 4 filed May 22, 2025
- 8SEC EDGARForm 4 filed Oct 17, 2024
- 9SEC EDGARForm 4 filed Aug 21, 2024
- 10SEC EDGARForm 4 filed Dec 1, 2022
- 11SEC EDGARForm 4 filed Oct 7, 2022
- 12SEC EDGARForm 4 filed Jul 8, 2022
- 13SEC EDGARForm 4 filed Apr 8, 2022